| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DGX | Common Stock | Award | $2,248,063 | +15,204 | +16% | $147.86 | 110,670 | 06 Mar 2023 | Direct | F1 |
| transaction | DGX | Common Stock | Tax liability | $1,188,203 | -8,036 | -7.3% | $147.86 | 102,634 | 06 Mar 2023 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2020, approved in accordance with the requirements of Rule 16b-3(d). |
| F2 | Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. |